1 blood cells, including lymphocytes, originate from the hematopoietic stem cells located in bone marrow (1, 2) . With the exception of T lymphocytes that require special thymic environment for maturation and selection (3), most of hematopoiesis takes place in the bone marrow. The existence of a sustained T cell development in the thymus requires a continuous input of precursor cells from bone marrow (4, 5) . However, we do not know whether bone marrowderived pluripotent stem cells come to the thymus and differentiate there into mature T cells, or if they start differentiating in the bone marrow and only immature, T-committed, precursor cells migrate into the thymus for further differentiation. Earliest T cell precursors in the adult murine thymus have recently been identified within the CD41~ population (6) . However, the sequence of differentiation events linking these precursor cells to the hematopoietic stem cell in the bone marrow is still unclear.
We have recently developed a mAb that reacts with the murine c-kit receptor tyrosine kinase (7) . The injection of the mAb into adult mice resulted within 2 d in a marked decrease in the number of peripheral erythroid and myeloid cells (8) . However, peripheral B cells were relatively increased in numbers and peripheral T cells and immature thymocytes remained unaffected by the treatment. Animals that received antibody treatment died of severe anemia before the effect on lymphoid cells became obvious. These findings suggested that the stem cells for the erythroid/myeloid lineages behaved differently from stem cells for lymphoid cells in the effect of anti-c-kit reagent. When we sorted c-kit + , Thy-1 l~ lineage marker negative cells (c-kit +, Thy-1 l~ Lin-) using a FACS | (Becton Dickinson Immunocytometry Systems, San Jose, CA) in adult bone marrow, the population thus highly enriched in stem cells displayed a capacity to reconstitute in the long term, all hematopoietic lineages including B and T lymphocytes (9) . Thus, the relative ineffectiveness of the anti-c-kit antibody treatment most likely reflects distinctive features of B and T lymphocytes in vivo.
To address the role of c-kit and of microenvironment in early lymphoid differentiation, we have attempted to establish an in vitro culture system in which T cells can be generated either from the bone marrow stem cells or from T-committed progenitors. In the present study, we have identified and characterized c-kit + Thy-11~ Lin-cells from the adult thymus (thymus c-kit cells) and compared them with cells of similar phenotype isolated from the bone marrow (BM 1 c-kit cells). Our results indicate that both thymus c-kit and BM c-kit cells can differentiate into T cells in the thymic environment and that thymus c-kit cells have lost the potential to differentiate into nonlymphoid cells. In addition, we show that, the generation ofT cells from BM c-kit cells is far more dependent on the c-kit-mediated signaling than that from thymus c-kit cells.
Materials and Methods
Mice. For the donor ofthymocytes and bone marrow cells, congenic mice C57BL/6J-Ly5.1:Pep3 b (B6-Ly 5.1) were bred and maintained in our animal facility. C57BL/6-N (B6-Ly 5.2) mice were purchased from Clea Japan (Tokyo, Japan) for the recipient of intra-thymic injection and spleen colony assay. Pregnant B6-Ly 5.2 mice, the donor of fetal thymus were purchased from SIC Inc. (Hamamatsu, Japan) at day 9 of pregnancy.
Antibodies. For cell sorting, biotinylated rat mAbs, RA-6B2 (anti-B220) (10), M1/70 (anti-Mac-I) (11), RA3-8C5 (anti-Gr-1) (12), GK1.5 (anti-L3T4) (13), 53-6.7 (anti-Ly 2) (14) , and TER119 (15) were used as lineage markers. FITC-labeled 30-H12 (anti-Thy-1.2) (16) and APC-conjugated ACK-2 (anti-c-kit) (7) were used as stem cell markers. B220, Mac-l, and GK1.5 were purified by affinity chromatography on immobilized protein A and were derivatized with biotin by standard techniques (17) . Ly 2-biotin and Thy-I.2-FITC were purchased from Becton Dickinson Immunocytometry Systems. Gr-l-biotin was purchased from Pharmingen (San Diego, CA). TER119-biotin were obtained from Dr. T. Kina (Kyoto University, Kyoto, Japan). Rat anti-c-k/t mAb was purified and conjugated with APC by standard method (17) . All biotinylated reagents were visualized by using Streptavidin-PE second step reagent (Becton Dickinson Immunocytometry Systems).
For analysis of reconstituted cells, mouse mAbs A20.1 (anti-Ly 5.1) obtained from Dr. Yumiko Saga (RIKEN, Tsukuba, Japan) and 104.2 (anti-Ly 5.2) obtained from Dr. Hidetaka Yakura (Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan) were derivatized with fluorescein or biotin, respectively. Rat anti-Ly 2 mAb was purified and labeled with allophycocyanin. PE-labeled GK1.5 was purchased from Becton Dickinson. PE-labeled B220 and Gr-1 and Ly 2, and FITC-labeled Mac-l, Gr-1, and anti-NKl.1 (PK136) (18) were purchased from Pharmingen.
Cell Preparation. Thymus glands were surgically excised from 4-6-wk-old female B6-Ly 5.1 mice. Thymus cell suspensions were prepared by pressing the tissue through a 100-gauge stainless steel mesh. Bone marrow cells were flushed from femurs with staining medium (PBS with 3% FCS and 0.1% sodium azide). The suspensions were filtered through a 200-gauge nylon mesh to remove debris.
Staining with Antibodies. 4 x 10 s of thymocytes or 4 x 107 of bone marrow cells were reacted with a cocktail of biotinylated rat mAbs specific for mouse differentiation antigens Gr-1, Mac-l, B220, TER119, CD4, and CD8 (see above for antibody designations) for 30 min at 4~ After washing the cells three times with staining medium, thymocytes were incubated in culture dishes, coated with sheep anti-rat immunoglobulins, and bone marrow cells were treated with magnetic bead-conjugated sheep anti-rat immunoglobulin (Dynabeads, Dynal, A.S., Oslo, Norway), for 30 Micro Intra-thymic Injection. Fetal thymus organ cultures and micro injections were done as described previously (19, 20) . Briefly, day 14 fetal thymic lobes from B6-Ly 5.2 mice were organ cultured on the surface of filters (0.8-mm pore size; Nucleopore Corporation, Pleasanton, CA) in 3.5 mm petri dishes containing 3 ml of RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (Bioproducts, Inc., Walkersville, MD), 1.35 mM 2'-deoxy guanosine (dGuo; Sigma Chemical Co., St. Louis, MO), 100 U/ml penicillin, and 100 gg/ml streptomycin for 6 d at 37"C under 5% COz in air. Each thymic lobe was then washed with RPMI and injected with 500-1,000 of sorted c-kit + Thy-1 I~ Lin-cells from 4 to 6 wk-old female B6-Ly 5.1 mice by using a micro manipulator (Narishige, Tokyo, Japan). After injection, the lobes were organ cultured for 8-24 d on the surface of 3 ml of 10% FCS supplemented RPMI 1640 medium. The reconstituted thymocytes were stained with anti-Ly 5.1, CD4, and CD8, and analyzed by FACS | Intra-thymic Injection. Intra-thymic injections of sorted c-kit + Thy-1 l~ Lin-thymocytes or bone marrow calls were performed under nembutal anesthesia (21). 6-8-wk-old female B6-Ly 5.2 mice were irradiated (6.5 Gy) within 6 h before surgery. 104 sorted kit + Thy-1 I~ Lin-thymocytes or bone marrow cells from 4-6-wk-old female B6-Ly 5.1 mice were injected into one thymic lobe of each recipient mouse in a volume of 5/zl. Mice were killed by neck dislocation at 8-24 d after injection and a cell suspension was prepared from each thymic lobes. The suspensions were stained and analyzed as described above.
In Vitro Colony Assay (CFU-C and HPP-CFC).
Methylcellulose culturing was carried out using a modification of the technique described by Iscove et al. (22) . 1 ml of culture medium contained an adequate number of sorted c-kit + Thy-1 z~ Lin-thymocytes or bone marrow cells, 1.2% methylcellulose (Fisher Scientific, Norcross, GA), or-medium (Flow Laboratories, North Ryde, Australia), 30% FCS (Flow Laboratories), 1% deionized BSA (Sigma Chemical Company), 0.1 mM 2-ME (Eastman Organic Chemical, Rochester, NY), and IL-3 (100 U/ml) and EPO (1 U/ml). In the case of high proliferative potential colony forming cell (HPP-CFC) assay, IL-1 (2 ng/ml), II,-3 (10 ng/ml), M-CSF (10 U/ml), GM-CSF (10 ng/ml), and stem cell factor (10 ng/ml) were added. The cultures were prepared in 35 mm nontissue culture dishes (Falcon Labware, Oxnard, CA) and incubated at 37~ in a humidified atmosphere of 5% COz. The number of colonies was counted after 14 d of culture using an inverted microscope.
In Vivo Colony Assay. Spleen colony assay was performed by using standard method (23). 10-14-wk-old B6-Ly 5.2 female mice were lethally irradiated at a dose of 9.5 Gy total body irradiation.
Unfractionated thymocytes or bone marrow cells, sorted c-kit + Thy-1 l~ Lin-thyrnocytes, or bone marrow cells were injected into the irradiated mice intravenously from the retro-orbital plexus. After injection, the spleens were removed at day 10, fixed in Bouin's solution, and macroscopically visible spleen colonies were counted.
Lineage Reconstitution Assay. 10,000 sorted thymus c-kit cells from B6-Ly 5.1 mice were injected into the sublethally irradiated B6-Ly 5.2 mice (8.7 Gy). 3 wk after injection, cells from the spleen and thymus were collected an d stained in three colors with donorspecific anti-Ly 5.1 (biotinylated) and lineage-specific antibodies (either FITC-conjugated anti-Gr-1, Mac-l, or NKI.1 and either PEconjugated anti-B220, GK 1.5, or Ly 2), followed by APC-avidin as a second step reagent. Three-color FACS | analysis was performed on the FACStar pi'| as described above.
Results

Presence o/c-kit + Thy-I t~ Lin-Cells among Thymocytes and Bone Marrow Cells.
It is known that pluripotent hematopoietic stem cells (HPSCs) in bone marrow express low levels of Thy-1 antigens and lack expression of surface markers that characterize cells within defined differentiated hematolymphoid call lineages (Thy-1 l~ and Lin-) (2, 24) . Our previous studies (9) have shown that pluripotent stem cells express high amount of c-kit molecules. We first tested thymocytes for the expression of c-kit. Four-color FACS | analysis with CD4 (PE), CD8 (FITC), Thy-1 (TK), and c-kit (APC) antibodies was performed with thymocytes from 6-wk-old B6-Ly 5.1 mice. Thymic cells expressing c-kit were not visible on a usual contour plot when total thymic population was analyzed without gating. However, when gates were set so that only the c-kit and Thy-1 expressions of CD4-CD8-thymocytes were examined, cells expressing c-kit were clearly detectable (Fig. 1) . These cells are c-kit + Thy-1 l~ but negative for Gr-1, Mac-l, B220, and TER119 (data not shown), just as c-kit-positive hematopoietic stem cells in bone marrow (9) . We assumed that c-kit-positive cells in thymus were PHSCs from bone marrow colonized in adult thymus, and the following experiments were performed to test this hypothesis.
Compared Stem Cell Activity of BM c-kit and Thymus c-kit. Fig. 2 demonstrates a staining profile of c-kit, Thy-1, and lineage markers among thymocytes and bone marrow cells. There exist a population of cells that are c-kit + Thy-1 lo Linboth in the bone marrow (BM c-kit calls) and in the thymus (thymus c-kit ceils). Approximately 0.5 _+ 0.2% of bone marrow cells and 0.07 +_ 0.03% of thymocytes are found to be in this population. To determine whether they possessed stem ceU activities, in vitro (CFU-C, HPP-CFC) and in vivo spleen colony assays (CFU-S) of sorted BM c-kit and thymus c-kit cells were performed. The results are summarized in Table 1 . When 10 s of unfractionated BM cells were injected into lethally irradiated mice, 13.2 _+ 1.3 colonies were observed on day 10. Although both of them are phenotypically identical, injection of thymus c-kit cells produced no spleen colonies out of 104 cells, whereas 1,000 sorted BM c-kit cells formed 11.6 _+ 0.8 colonies.
In CFU-C assay, sorted BM c-kit calls formed 43 _+ 4.5 colonies per 200 cells in the presence of IL-3 and EPO. Formed colonies were granulocyte-macrophage colonies, erythroid bursts, and mixed colonies. Thus, approximately one fifth of BM c-kit formed colonies, which provided an approximately 35-fold enrichment of CFU-C. On the other hand, sorted thymus c-kit cells formed colonies only at a frequency of 1/2,500 in CFU-C assay.
Since these cells express c-kit, we added its ligand, stem ceil factor, along with IL-1, IL-3, M-CSF, and GM-CSF in the medium for in vitro colony assay. This type of CFU-C (HPP-CFU) assay is known to detect the earliest hematopoietic stem cells (25, 26 As shown from the results of three independent experiments, both BM and thymus c-kit cells differentiated into T cells in organ culture (Fig. 4 A) . However, CD4CD8 double positive thymocytes differentiated 3-4-d later out of BM c-kit cells than out of thymus c-kit cells (Fig. 4 B) . This difference The c-kit+ Thy-llo Lin-cells from both bone marrow and thymus were sorted on the basis of staining analysis (Fig. 2) . Stem cell assays were performed with both fractions and unfractionated bone marrow cells and thymocytes. * Numbers of colonies in the presence of IL-3 and EPO at day 14. * Cells were injected into irradiated B6 mice intravenously and the number of spleen colonies were counted at day 10. S Number of colonies in the presence of IL-1, IL-3, M-CSF, GM-CSF, and SCF(KL) at day 14. Mean +_ SD for quadruplicates. As discussed above, we assumed that BM c-kit shifted for thymus c-kit during first 4 d, and thus, we speculated that c-kit is required in this duration. To prove this hypothesis, 
Lymphoid and NK Cells Restricted Differentiation Capacity of Thymus c-kit Cells.
To define further the developmental potential of the thymus c-kit calls, the system of intravenous transfer into mice differing at the Ly 5 locus was used (31) . We analyzed ceils in the spleen and thymus 3 wk after transfer. Given that a bone marrow stem cell has a large proliferative capacity, only a few ceils each a month are necessary to sustain T lymphocyte proliferation in the thymus (32) . These few ceils could not be detected as such. We presently favor the hypothesis according to which some bone marrow stem cells, rather than T-committed progenitors, migrate to the thymus and differentiate there into T cells.
Irrespective of the place they are formed, are thymus c-kit cells the earliest T cell progenitors in the thymus? According to Wu et al. (6, 33) , the earliest precursor cells in the adult mouse thymus are CD4 dull positive cells. We have therefore analyzed the surface phenotype of thymus c-kit cells using four-color FACS | analysis. We could identify the presence of CD4 ~ thymocytes among the thymic c-kit-positive population. However, as far as we carefully studied, majority of thymus c-kit ceils that we used in our experiments did not express CD4. Judging from the experimental procedure used by Wu et al., (6, 33) it is likely that the cell population they studied included the thymus c-kit cells we describe here. Thus, the characteristics of the CD4 I~ precursor cells they reported could have been at least in part those of thymus c-kit cells. Precise developmental relationship between thymus c-kit cells and "low CD4 precursor" remains to be determined. 
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, . topoietic stem cells in the bone marrow that we and others have reported (34) (35) (36) and which appear to be independent of the Lin-Thy-11~ stem cells. More precise analysis using multi-parameter cell sorting and organ culture, preferably at -~176 t Days of culture a single cell level, should aid to clarify the chronological relationships among these cell populations. Molecular events that take place during these 3 d required for transition from BM c-kit to thymus c-kit are our main current focus of attention. A study on the role of c-kit during early T cell differentiation may constitute a due to the underlying molecular events. In this respect, the finding that the anti-c-kit antibody blocked T cell differentiation of BM c-kit cells but not that of thymus c-kit cells can be of primary importance. Thymus c-kit cells may not be totally independent of c-kit, since recent report by Godfrey et al. (37) showed that c-kit + thymocytes proliferated in the presence of SCF and IL-7 and that this proliferation was blocked by the antic-kit antibody at higher concentration (50 gg/ml). However, it is evident from our data that BM c-kit and thymus c-kit cells are different in terms of dependency on the c-kitmediated signaling. Thymus c-kit cells have lost their capacity to differentiate into nonlymphoid cells, whereas on the other hand, they have become less dependent on the c-kit-mediated signals. Thus, lymphoid committed progenitors would proliferate and differentiate under the control of other lineagespecific signals such as IL-2 or IL-7 (38) (39) (40) and may use c-kit in different way than BM c-kit. The function of c-kit in the T cell progenitor cells can be approached through the fact that the ligand for c-kit (KL) is expressed in fetal thymus (41) . It is not known whether KL expressed in the thymus is membrane bound, soluble, or sequestered. If the membranebound form of KL is expressed on epithelial or stromal cells of the thymus, c-kit may play a role as a kind of adhesion molecule ensuring the migration to the proper micro environment within the thymus.
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Lastly, we showed that thymus c-kit cells had a potential to differentiate into NKI.1 + cells upon intravenous injection. The developmental origin of NK cells and the relationship between T celt and NK cell precursors have been con- troversial. Some investigators have supported an assignment of NK cells to the myeloid or the monocytic lineage (42, 43) . On the other hand, a recent report by Rodewald et al. (44) suggested the presence of a common T/NK precursor in the thymus. Although it requires a clonal assay system to draw a definite conclusion, our data support the idea that NK cells and T cells have a common progenitor.
